Home › Funds › C WorldWide Group Holding A/S › IONS
C WorldWide Group Holding A/S position in IONS
IONIS PHARMACEUTICALS INC · Health Care
C WorldWide Group Holding A/S reported holding 366,000 shares of IONS (IONIS PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$16.3M, representing 0.41% of its reported portfolio and ranking #37 among its reported holdings. C WorldWide Group Holding A/S has disclosed IONS holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How C WorldWide Group Holding A/S's IONS position evolved
C WorldWide Group Holding A/S first disclosed a stake in IONS in Q4 2023 at 300,000 shares (US$15.2M). The position peaked in Q2 2026 at 366,000 shares, worth US$29.0M. Across 12 filings, C WorldWide Group Holding A/S increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 366,000 shares valued at US$16.3M. Notable position changes include a 33% increase in Q4 2024 (shares fell 14% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 300.00K | $15.18M | New |
| Q1 2024 | 300.00K | $13.01M | Hold |
| Q2 2024 | 300.00K | $14.30M | Hold |
| Q3 2024 | 300.00K | $12.02M | Hold |
| Q4 2024 | 400.00K | $13.98M | Add |
| Q1 2025 | 400.00K | $12.07M | Hold |
| Q2 2025 | 450.00K | $17.78M | Add |
| Q3 2025 | 426.00K | $27.87M | Reduce |
| Q4 2025 | 366.00K | $28.95M | Reduce |
| Q1 2026 | 366.00K | $27.48M | Hold |
| Q2 2026 | 366.00K | $29.02M | Hold |
| Q3 2026 | 366.00K | $16.34M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IONS and 13F data
IONS (IONIS PHARMACEUTICALS INC) is a Health Care company. 34 other funds we track also report a position in IONS — the largest reported positions include Two Sigma Investments (US$495.7M), TWO SIGMA ADVISERS, LP (US$241.5M), Deep Track Capital, LP (US$174.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IONS
- Two Sigma Investments 6.25M sh · $495.75M · Q2 2026
- TWO SIGMA ADVISERS, LP 3.05M sh · $241.45M · Q4 2025
- Deep Track Capital, LP 2.20M sh · $174.44M · Q2 2026
- BAKER BROS. ADVISORS LP 2.05M sh · $162.36M · Q2 2026
- TENOR CAPITAL MANAGEMENT Co., L.P. 94.68M sh · $147.77M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 60.00M sh · $93.10M · Q2 2026
- Tweedy, Browne Co LLC 1.79M sh · $80.08M · Q3 2026
- Bellevue Group AG 972.26K sh · $77.09M · Q2 2026
- GROUPAMA ASSET MANAGMENT 937.08K sh · $75.20M · Q2 2026
- SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 787.26K sh · $62.42M · Q2 2026
More on C WorldWide Group Holding A/S
FAQ
How long has C WorldWide Group Holding A/S held IONS?
C WorldWide Group Holding A/S has disclosed IONS holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
What is C WorldWide Group Holding A/S's current position in IONS?
As of Q3 2026, C WorldWide Group Holding A/S holds 366.00K shares of IONS (IONIS PHARMACEUTICALS INC), valued at $16.34M, representing 0.41% of its reported portfolio and ranking #37.
Has C WorldWide Group Holding A/S been buying or selling IONS?
In the latest 13F filing (Q3 2026), C WorldWide Group Holding A/S held unchanged its position in IONS. The position peaked in Q2 2026 at 366.00K shares.
Which other funds hold IONS?
Other major institutional holders of IONS include Two Sigma Investments, TWO SIGMA ADVISERS, LP, Deep Track Capital, LP, among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.